Progestogen News and Research

RSS

Good tidings for women on HRT

For many women struggling to deal with the symptoms of the menopause, the latest research on hormone replacement therapy (HRT) bears good tidings.

25 Aug 2008

Confused about HRT? read on!

As if women are not confused enough about the pros and cons of hormone replacement therapy (HRT), an international group of experts now say safety issues regarding HRT have been "over hyped".

20 May 2008

For older women HRT a risky option

According to an international study older women should not take Hormone Replacement Therapy (HRT).

12 Jul 2007

Merits and risks of postmenopausal hormone therapy

The study was categorized as a primary prevention trial for coronary heart disease, although the fact that mean age at recruitment was 63 years was not given enough importance at that time. WHI investigators concluded that hormone therapy (HT) was not cardioprotective, and, in fact, its riskbenefit ratio did not favor the use of postmenopausal hormones for prevention of chronic diseases.

17 May 2007

New natural contraceptive pill being trialled

University of Adelaide researchers, together with the Adelaide Hormone and Menopause Centre, are trialling a new natural contraceptive pill alternative.

24 Jul 2006

Putting the risk of breast cancer and postmenopausal Hormone Therapy (HT) into perspective

Two similar comprehensive literature reviews and an editorial about the varying risk with different postmenopausal hormone therapy regimens have been published this month in Human Reproduction Update.

7 Sep 2005

New study says HRT risks far lower

Women battling to deal with the miserable effects of the menopause, will be even more confused by the release of a new Australian study, which says that a woman's risk of developing breast cancer after taking hormone replacement therapy (HRT) might be lower than previously thought.

7 Aug 2005

Studies examine menopausal hormone therapy and risk of breast cancer recurrence

The doses of estrogen and progestogen used in menopausal hormone therapy may be related to the risk of breast cancer recurrence, according to a new study in the April 6 issue of the Journal of the National Cancer Institute.

5 Apr 2005